Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

Bioventus (Nasdaq: BVS) will report first-quarter fiscal 2026 financial results before market open on May 6, 2026.

Rhea-AI Summary

Bioventus (Nasdaq: BVS) will report first-quarter fiscal 2026 financial results before market open on May 6, 2026. Management will host a conference call at 8:30 a.m. ET the same day and provide a live webcast and materials via the company investor relations site. The webcast will be archived through May 5, 2027.

Argus Apr 29 session

-2.91% close to close Open Argus

Details

News Market Reaction – BVS

On Apr 29, the first trading day after this news, BVS closed 2.91% below the previous close.

Data tracked by StockTitan Argus for the Apr 29 session.

Market Context

This announcement sets Bioventus’s Q1 fiscal 2026 earnings release for May 6, 2026, including an 8:3...

Analysis

This announcement sets Bioventus’s Q1 fiscal 2026 earnings release for May 6, 2026, including an 8:30 a.m. ET conference call and webcast with a replay through May 5, 2027. Historically, similar earnings-date notices have produced only modest price moves, while full earnings reports have driven more substantial reactions. Investors may focus on how upcoming results compare with prior 2025 performance and previously communicated guidance, using the call for additional operational and strategic context.

Key Figures

Earnings release date: May 6, 2026 Conference call time: 8:30 a.m. Eastern Time Dial-in number: 1-833-636-0497 +1 more

Earnings release date

May 6, 2026

Q1 fiscal 2026 results to be reported before market open

Conference call time

8:30 a.m. Eastern Time

Scheduled management call to discuss Q1 FY 2026 results

Dial-in number

1-833-636-0497

Investor access line for the Q1 FY 2026 conference call

Webcast replay end date

May 5, 2027

Archived Q1 FY 2026 call available on Investor Relations site

Previous Earnings date Reports

1 past event · Latest: Feb 24

Same Type 1 event

1. Feb 24

   Earnings date notice

   24h Move

   +0.3%

   Set Q4 2025 results date with conference call and webcast details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2026 before the market opens on Wednesday, May 6, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until May 5, 2027.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com  

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bioventus (BVS) report Q1 fiscal 2026 results and what time is the conference call?

Bioventus will report Q1 fiscal 2026 results before market open on May 6, 2026 and host a conference call at 8:30 a.m. ET. According to the company, management will discuss results and provide a business update on that call.

How can investors join the Bioventus (BVS) conference call on May 6, 2026?

Investors can join by dialing 1-833-636-0497 and referencing the Bioventus Inc. Conference Call. According to the company, a live webcast and accompanying materials will be available on the investor relations website.

Where will Bioventus (BVS) host the webcast and how long will the replay be available?

The live webcast and materials will be hosted on the company's investor relations website at https://ir.bioventus.com/. According to the company, the webcast archive will be available for replay through May 5, 2027.

Will Bioventus (BVS) provide presentation materials for the May 6, 2026 earnings call?

Yes. Presentation materials and a live webcast will be provided on the investor relations website. According to the company, those materials will accompany the call and be archived for later replay and review.

What topics will Bioventus (BVS) management cover on the May 6, 2026 call?

Management will discuss first-quarter fiscal 2026 financial results and provide a business update on the conference call. According to the company, the call is intended to review performance and share current operational information.